Adamax
Adamantane-conjugated Semax peptide with enhanced BBB penetration and prolonged neurotrophic action.
Pharmacology
Contents
WHAT IS ADAMAX?
Detailed overview
Adamax is an adamantyl-conjugated derivative of the Russian Semax peptide (ACTH 4-10 analog, sequence Met-Glu-His-Phe-Pro-Gly-Pro). The modification serves two purposes: (1) increased blood-brain barrier permeability via higher lipophilicity, (2) N-terminal peptidase resistance, so intranasal dosing produces ~5-10× longer CNS exposure than plain Semax. Publications from Lomonosov Moscow State University and Bulletin of Experimental Biology and Medicine (PMID 31075176) demonstrate BDNF/NGF-inducer effects and an anxiolytic profile in animal models (forced swim test, elevated plus maze). No human clinical trials exist; only user anecdotes and preclinical PK data are available. The adamantyl group recurs in other nootropics (Bromantane, Memantine) – a shared theme of improving CNS permeation.
Mechanism
Melanocortin (MCR3/4) + BDNF/NGF inducer
Half-life
4-6 h (intranasal, animal PK)
Legal status
EU/USA: research compound, not approved
Receptor profile
- BDNF / TrkBStrong
- Enkephalin-degrading enzymesModerate
- Blood-brain barrier penetration (adamantane)Moderate
Safety
Side effects, stop signs, contraindications
Side effects · 6
- Limited human safety data, side-effect profile is mainly preclinical and anecdotal
- Intranasal use may cause nasal mucosa irritation, stinging and sneezing
- Headache and transient irritability (anecdotally reported with the parent Semax)
- Overstimulation, restlessness or sleep disturbance, especially with late-evening dosing
- Mood swings or anxiety-like sensations in some user reports
- Unknown long-term safety, chronic effects of the adamantyl modification are unstudied
Contraindications · 5
- Avoid during pregnancy and breastfeeding, no safety data available
- Unapproved research compound without human clinical trials, not recommended without medical supervision
- Caution with anxiety, mood disorders or ongoing psychiatric treatment due to neuroactive effects
- Avoid combining with other CNS-active agents, stimulants or peptides, interactions are unknown
- Purity and composition not guaranteed from grey-market sources, risk of contamination
Related Nootropics
Same therapeutic category
FAQ
FAQ
Adamax is a modified version of the Russian peptide Semax, with a fat-soluble group attached to help it cross the blood-brain barrier more easily and act for longer. The idea is that it would give a stronger, longer-lasting boost to the brain's own growth-factor (neurotrophic) signaling, but since this is an experimental/community modification, no concrete human trial data on its effects is given in the source.
Telegram
Have a question about Adamax?
Reach out to us on Telegram for a personalized stack. We'll be happy to help.
Personalized consultation
Want a detailed conversation tailored to your data?
Fill out the prep intake form (your goals, training and health data), and the advisor prepares from it to give genuinely personalized guidance.
Fill out the form~5–7 min · prep questionnaire · confidential · GDPR-compliant
Structure & chemistry
The information here is strictly for educational and scientific purposes. It does not replace medical advice or clinical consultation, and it does not encourage illegal substance or pharmaceutical use. Data is sourced. When in doubt, consult your doctor.